Litcius/Paper detail

Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021

Chao Ma, Weiwei Sun, Tingting Tang, Manhong Jia, Yonghua Liu, Yongfang Wan, Jizhou Han, Lance E. Rodewald, Junhong Li, Yudan Song, Yamin Wang, Dan Wu, Fuzhen Wang, Hui Zheng, Lin Tang, George F. Gao, Zundong Yin, Zhijie An

2022Vaccine37 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationPneumoniaCoronavirus disease 2019 (COVID-19)PandemicOutbreakVirologyRetrospective cohort studyLogistic regressionInternal medicineImmunologyDiseaseInfectious disease (medical specialty)Virus-based gene therapy researchSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021 | Litcius